Cargando…

Assessment of Spanish Panel Reactive Antibody Calculator and Potential Usefulness

BACKGROUND AND OBJECTIVES: The calculated panel reactive of antibodies (cPRAs) necessary for kidney donor-pair exchange and highly sensitized programs are estimated using different panel reactive antibody (PRA) calculators based on big enough samples in Eurotransplant (EUTR), United Network for Orga...

Descripción completa

Detalles Bibliográficos
Autores principales: Asensio, Esther, López-Hoyos, Marcos, Romón, Íñigo, Ontañón, Jesús, San Segundo, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5425465/
https://www.ncbi.nlm.nih.gov/pubmed/28553286
http://dx.doi.org/10.3389/fimmu.2017.00540
_version_ 1783235305247080448
author Asensio, Esther
López-Hoyos, Marcos
Romón, Íñigo
Ontañón, Jesús
San Segundo, David
author_facet Asensio, Esther
López-Hoyos, Marcos
Romón, Íñigo
Ontañón, Jesús
San Segundo, David
author_sort Asensio, Esther
collection PubMed
description BACKGROUND AND OBJECTIVES: The calculated panel reactive of antibodies (cPRAs) necessary for kidney donor-pair exchange and highly sensitized programs are estimated using different panel reactive antibody (PRA) calculators based on big enough samples in Eurotransplant (EUTR), United Network for Organ Sharing (UNOS), and Canadian Transplant Registry (CTR) websites. However, those calculators can vary depending on the ethnic they are applied. Here, we develop a PRA calculator used in the Spanish Program of Transplant Access for Highly Sensitized patients (PATHI) and validate it with EUTR, UNOS, and CTR calculators. METHODS: The anti-human leukocyte antigen (HLA) antibody profile of 42 sensitized patients on waiting list was defined, and cPRA was calculated with different PRA calculators. RESULTS: Despite different allelic frequencies derived from population differences in donor panel from each calculator, no differences in cPRA between the four calculators were observed. The PATHI calculator includes anti-DQA1 antibody profiles in cPRA calculation; however, no improvement in total cPRA calculation of highly sensitized patients was demonstrated. INTERPRETATION AND CONCLUSION: The PATHI calculator provides cPRA results comparable with those from EUTR, UNOS, and CTR calculators and serves as a tool to develop valid calculators in geographical and ethnic areas different from Europe, USA, and Canada.
format Online
Article
Text
id pubmed-5425465
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-54254652017-05-26 Assessment of Spanish Panel Reactive Antibody Calculator and Potential Usefulness Asensio, Esther López-Hoyos, Marcos Romón, Íñigo Ontañón, Jesús San Segundo, David Front Immunol Immunology BACKGROUND AND OBJECTIVES: The calculated panel reactive of antibodies (cPRAs) necessary for kidney donor-pair exchange and highly sensitized programs are estimated using different panel reactive antibody (PRA) calculators based on big enough samples in Eurotransplant (EUTR), United Network for Organ Sharing (UNOS), and Canadian Transplant Registry (CTR) websites. However, those calculators can vary depending on the ethnic they are applied. Here, we develop a PRA calculator used in the Spanish Program of Transplant Access for Highly Sensitized patients (PATHI) and validate it with EUTR, UNOS, and CTR calculators. METHODS: The anti-human leukocyte antigen (HLA) antibody profile of 42 sensitized patients on waiting list was defined, and cPRA was calculated with different PRA calculators. RESULTS: Despite different allelic frequencies derived from population differences in donor panel from each calculator, no differences in cPRA between the four calculators were observed. The PATHI calculator includes anti-DQA1 antibody profiles in cPRA calculation; however, no improvement in total cPRA calculation of highly sensitized patients was demonstrated. INTERPRETATION AND CONCLUSION: The PATHI calculator provides cPRA results comparable with those from EUTR, UNOS, and CTR calculators and serves as a tool to develop valid calculators in geographical and ethnic areas different from Europe, USA, and Canada. Frontiers Media S.A. 2017-05-11 /pmc/articles/PMC5425465/ /pubmed/28553286 http://dx.doi.org/10.3389/fimmu.2017.00540 Text en Copyright © 2017 Asensio, López-Hoyos, Romón, Ontañón and San Segundo. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Asensio, Esther
López-Hoyos, Marcos
Romón, Íñigo
Ontañón, Jesús
San Segundo, David
Assessment of Spanish Panel Reactive Antibody Calculator and Potential Usefulness
title Assessment of Spanish Panel Reactive Antibody Calculator and Potential Usefulness
title_full Assessment of Spanish Panel Reactive Antibody Calculator and Potential Usefulness
title_fullStr Assessment of Spanish Panel Reactive Antibody Calculator and Potential Usefulness
title_full_unstemmed Assessment of Spanish Panel Reactive Antibody Calculator and Potential Usefulness
title_short Assessment of Spanish Panel Reactive Antibody Calculator and Potential Usefulness
title_sort assessment of spanish panel reactive antibody calculator and potential usefulness
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5425465/
https://www.ncbi.nlm.nih.gov/pubmed/28553286
http://dx.doi.org/10.3389/fimmu.2017.00540
work_keys_str_mv AT asensioesther assessmentofspanishpanelreactiveantibodycalculatorandpotentialusefulness
AT lopezhoyosmarcos assessmentofspanishpanelreactiveantibodycalculatorandpotentialusefulness
AT romoninigo assessmentofspanishpanelreactiveantibodycalculatorandpotentialusefulness
AT ontanonjesus assessmentofspanishpanelreactiveantibodycalculatorandpotentialusefulness
AT sansegundodavid assessmentofspanishpanelreactiveantibodycalculatorandpotentialusefulness